Uric acid excretion and dopamine-induced glomerular filtration response in patients with IgA glomerulonephritis

American Journal of Nephrology

Volumn 28, Issue 3, 2008, Pages 391-396

  Sulikowska, Beata ^a   Manitius, Jacek ^a,d   Odrowa̧z Sypniewska, Grazyna ^a,b   Łysiak Szydłowska, Wiesława ^c   Rutkowski, Bolesław ^c  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d Department of Nephrology Hypertension and Internal Medicine ^*  (Poland)

Author keywords

IgA glomerulonephritis; Intrarenal vessel function; N Acetyl D glucosaminidase; Uric acid

Indexed keywords

CHOLESTEROL; DOPAMINE; N ACETYL BETA GLUCOSAMINIDASE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEINURIA; REGRESSION ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; TUBULAR DYSFUNCTION; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

ACETYLGLUCOSAMINIDASE; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DOPAMINE; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; MIDDLE AGED; RENAL CIRCULATION; URIC ACID;

EID: 41849107993     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112271     Document Type: Article

References (30)

1. D'Amico D: Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000;36:227-237.
2. Myllymäki J, Honkanen T, Syrjänen J, Helin H, Rantala I, Pasternack A, Mustonen J: Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Nephrol Dial Transplant 2005;20:89-95.
3. Syrjänen J, Mustonen J, Pasternack A: Hypertriglyceridemia and hyperuricemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 2000;15:34-42.
4. Mazzali M, Hughes J, Kim YG, Jefferson A, Kang DH, Gordon KL, Lan HY, Kivlinghan S, Johnson RJ: Elevated uric acid increases blood pressure in the rat by novel crystal-independent mechanism. Hypertension 2001;38:1101-1106.
5. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ: A role of uric acid in the progression of renal disease. J Am Soc Nephrol 2002;13:2888-2897.
6. Manitius J, Biedunkiewicz B, Kustosz J, Rutkowski B: The relationship between insulin, glucose and serum uric acid and their contribution to the progression of renal damage in patients with primary glomerulonephritis. J Int Med Res 1996;24:449-453.
7. Sulikowska B, Niewȩgłowski T, Manitius J, Łysiak-SzydŁowska W, Rutkowski B: Effect of 12-month therapy with omega-3 polyunsaturated acids on glomerular filtration response to dopamine in IgA nephropathy. Am J Nephrol 2004;24:474-482.
8. Smit AJ, Meijer S, Wessling H, Reitsma WD, Donker AJ: Impaired renal hemodynamics but conserved natriuretic response to dopamine in patients with renal disease. Nephron 1989;52:338-346.
9. Bosomworth MP, Aparicio SR, Hay AW: Urine N-acetyl-β- glucosaminidase. A marker of tubular damage? Nephrol Dial Transplant 1999;14:620-626.
10. Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G: N-acetyl-β-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002;17:1890-1896.
11. Perlstein TS, Gumieniak O, Hopkins PN, Murphey LJ, Brown NJ, Williams GH, Hollenberg NK, Fisher ND: Uric acid and the state of the intrarenal renin-angiotensin systems in humans. Kidney Int 2004;66:1465-1470.
12. Futrakul N, Tohsukhowong P, Patumraj S, Siriviriyakuk P, Tipprukmas N, Futrakul P: Treatments of hemodynamic maladjustment and oxidative stress prevent renal disease progression in chronically severe glomerulonephritides. Ren Fail 2003;25:839-844.
13. Futrakul N, Vongthavarawat V, Sirisalipotch S, Cairatanarat T, Futrakul P, Sunwanwalaikorn S: Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes. Clin Hemorheol Microcirc 2005;32:59-65.
14. Sánchez-Lozada LG, Tapia E, Santamaría J, Avila-Casado C, Soto V, Nepomuceno T, Rodríguez-Iturbe B, Johnson RJ, Herrera-Acosta J: Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 2005;67:237-247.
15. Messerli FH, Fröhlich ED, Dreslinski GR, Suarez DH, Aristimuno GG: Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 1980;93:817-821.
16. Nangaku M: Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006;17:17-25.
17. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ: Hyperuricemia induces a primary renal arteriolopathy in rats by blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002;282:F991-F997.
18. Mercuro G, Vitale C, Cerquentani E, Zoncu S, Deidda M, Fini M, Rosano GM: Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004;94:932-935.
19. Farquarson CA, Butler R, Hill A, Belch JJ, Struthers AD: Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002;106:221-226.
20. Petricone F, Maio R, Tripepi G, Zoccali C: Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 2004;110:821-825.
21. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ: Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002;13:806-816.
22. Myllymäki J, Syrjänen J, Helin H, Pasternack A, Kattainen A, Mustonen J: Vascular diseases and their risk factors in IgA nephropathy. Nephrol Dial Transplant 2006;21:1876-1882.
23. Roch-Ramel F, Diezi J: Renal transport of organic ions and uric acid; in Schrier RW, Gottschalk CW (eds): Diseases of the Kidney, ed 6. Boston, Little, Brown, 1996, pp 231-249.
24. Garcia Puig J, Mateos Antón F, Muños Sanz A, Gaspar G, Lesmes A, Ramos T, Ortiz Vázquez J: Renal handling of uric acid in normal subjects by means of the pyrazinamide and probenecid tests. Nephron 1983;35:183-186.
25. Eiro M, Katoh T, Sakuma Y, Sakurai K, Suzuki H, Asahi K, Watanabe K, Watanabe T: Insulin resistance highly associates with hypertension in IgA nephropathy. Clin Nephrol 2003;59:71-78.
26. Zandi-Nejad K, Eddy AA, Glassock RJ, Brenner BM: Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int Suppl 2004;92:S76-S89.
27. Bosch JP: Renal reserve:a functional view of glomerular filtration rate. Semin Nephrol 1995;15:381-385.
28. Grunfeld B, Perelstein E, Simsolo R, Gimenez M, Romero JC: Renal functional reserve and microalbuminuria in offspring of hypertensive parents. Hypertension 1990;15:257-261.
29. Steinhausen M, Weis S, Fleming J, Dussel R, Parekh N: Responses of in vivo renal microvessels to dopamine. Kidney Int 1986;30:361-370.
30. Jacobson HR: Functional segmentation of the mammalian nephron. Am J Physiol 1981;241:F203-F218.